Antibiotic resistance is a critical challenge in healthcare, especially among the elderly, where multidrug-resistant organisms (MDROs) contribute to increased morbidity, mortality, and healthcare costs. This review discusses the mechanisms of resistance in key bacterial pathogens, risk factors that make the elderly susceptible to MDRO infections, and strategies to mitigate resistance. The elderly are particularly vulnerable due to factors such as immunosenescence, frailty, multimorbidity, and frequent hospitalization. MDROs include MRSA, VRE, S. pneumoniae, Enterobacteriaceae, C. difficile, M. tuberculosis, P. aeruginosa, and A. baumannii, each with distinct resistance mechanisms. Strategies to combat antibiotic resistance include the development of novel antibiotics like teixobactin, cefiderocol, murepavadin, and plazomicin, as well as bacteriophage therapy, antivirulence therapies, probiotics, fecal microbiota transplantation, and vaccine development. Innovative approaches such as multi-epitope vaccines and nanoparticle-based vaccines show promise in enhancing protection against MDROs. Machine learning is also explored for predicting resistance patterns and aiding in vaccine and antibiotic development. The review emphasizes the importance of multidisciplinary efforts to address the global challenge of antibiotic resistance in aging populations.Antibiotic resistance is a critical challenge in healthcare, especially among the elderly, where multidrug-resistant organisms (MDROs) contribute to increased morbidity, mortality, and healthcare costs. This review discusses the mechanisms of resistance in key bacterial pathogens, risk factors that make the elderly susceptible to MDRO infections, and strategies to mitigate resistance. The elderly are particularly vulnerable due to factors such as immunosenescence, frailty, multimorbidity, and frequent hospitalization. MDROs include MRSA, VRE, S. pneumoniae, Enterobacteriaceae, C. difficile, M. tuberculosis, P. aeruginosa, and A. baumannii, each with distinct resistance mechanisms. Strategies to combat antibiotic resistance include the development of novel antibiotics like teixobactin, cefiderocol, murepavadin, and plazomicin, as well as bacteriophage therapy, antivirulence therapies, probiotics, fecal microbiota transplantation, and vaccine development. Innovative approaches such as multi-epitope vaccines and nanoparticle-based vaccines show promise in enhancing protection against MDROs. Machine learning is also explored for predicting resistance patterns and aiding in vaccine and antibiotic development. The review emphasizes the importance of multidisciplinary efforts to address the global challenge of antibiotic resistance in aging populations.